Medically Home received the funding from Kaiser Permanente and Mayo Clinic, both of which are already using its home care technology.

Pancreatic cancer test developer Bluestar Genomics has raised $70m from investors including Pathology Asia Holdings.

Dell Technologies Capital returned for a series B round in which the machine learning technology developer hiked its overall funding to $120m.

Based on research at Stanford, Bluestar Genomics is working on a non-invasive test for pancreatic cancer.

Vanderbilt’s Center for Technology Transfer and Commercialization generated nine new companies in 2020 and licensed a significant number of covid-related technologies.

Short-term accommodation provider Cohabs secured more than $70m in a round led by AG Real Estate, while Stampli, Impress and Tarana Wireless each raised $50m.

Simon Ventures-backed electric scooter rental service Bird is getting a New York Stock Exchange listing through the merger with Switchback II Corporation.

Duke University will launch its Research Translation and Commercialization effort in July to expand its capacity to generate more spinouts and accelerate discoveries.

Alexandria Venture Investments has returned to take part in the seed technology developer’s series D round at a $1.2bn valuation, helping to take its total funding to $352m.

The health data analytics provider counts Johnson & Johnson, McKesson, Amgen, Sanofi, UCB Pharma and Blue Cross Blue Shield of New Jersey as earlier investors.